{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T07:15:59Z","timestamp":1783149359720,"version":"3.54.6"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jcf.2026.04.007","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T13:36:13Z","timestamp":1778592973000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Progress and challenges in cystic fibrosis gene editing"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0037-5999","authenticated-orcid":false,"given":"Jacob","family":"Witten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Egan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Cereseto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2026.04.007_bib0001","doi-asserted-by":"crossref","first-page":"4091","DOI":"10.1016\/j.ymthe.2025.06.021","article-title":"CRISPR for cystic fibrosis: advances and insights from a systematic review","volume":"33","author":"Nicosia","year":"2025","journal-title":"Mol Ther"},{"key":"10.1016\/j.jcf.2026.04.007_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2025.111979","article-title":"Adenine base editing with engineered virus-like particles rescues the CFTR mutation G542X in patient-derived intestinal organoids","volume":"28","author":"Nicosia","year":"2025","journal-title":"iScience"},{"key":"10.1016\/j.jcf.2026.04.007_bib0003","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184009","article-title":"Cas9\/gRNA targeted excision of cystic fibrosis-causing deep-intronic splicing mutations restores normal splicing of CFTR mRNA","volume":"12","author":"Sanz","year":"2017","journal-title":"PLOS One"},{"key":"10.1016\/j.jcf.2026.04.007_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2023.101140","article-title":"Molecular and functional correction of a deep intronic splicing mutation in CFTR by CRISPR-Cas9 gene editing","volume":"31","author":"Walker","year":"2023","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.jcf.2026.04.007_bib0005","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1038\/s41467-019-11454-9","article-title":"Allele specific repair of splicing mutations in cystic fibrosis through AsCas12a genome editing","volume":"10","author":"Maule","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jcf.2026.04.007_bib0006","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.omtm.2020.05.002","article-title":"Allele-specific prevention of nonsense-mediated decay in cystic fibrosis using homology-independent genome editing","volume":"17","author":"Erwood","year":"2020","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.jcf.2026.04.007_bib0007","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nature20565","article-title":"In vivo genome editing via CRISPR\/Cas9 mediated homology-independent targeted integration","volume":"540","author":"Suzuki","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jcf.2026.04.007_bib0008","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1093\/hmg\/ddad143","article-title":"Use of adenine base editing and homology-independent targeted integration strategies to correct the cystic fibrosis causing variant, W1282X","volume":"32","author":"Mention","year":"2023","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jcf.2026.04.007_bib0009","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.stem.2013.11.002","article-title":"Functional repair of CFTR by CRISPR\/Cas9 in intestinal stem cell organoids of cystic fibrosis patients","volume":"13","author":"Schwank","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jcf.2026.04.007_bib0010","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.omtn.2019.02.006","article-title":"Efficient gene editing at major CFTR mutation loci","volume":"16","author":"Ruan","year":"2019","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.jcf.2026.04.007_bib0011","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.celrep.2015.07.062","article-title":"Functional gene correction for cystic fibrosis in lung epithelial cells generated from patient iPSCs","volume":"12","author":"Firth","year":"2015","journal-title":"Cell Rep"},{"key":"10.1016\/j.jcf.2026.04.007_bib0012","doi-asserted-by":"crossref","DOI":"10.1038\/srep32230","article-title":"Analysis of gene repair tracts from Cas9\/gRNA double-stranded breaks in the human CFTR gene","volume":"6","author":"Hollywood","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcf.2026.04.007_bib0013","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.stem.2019.11.002","article-title":"High-efficiency, selection-free gene repair in airway stem cells from cystic fibrosis patients rescues CFTR function in differentiated epithelia","volume":"26","author":"Vaidyanathan","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jcf.2026.04.007_bib0014","doi-asserted-by":"crossref","first-page":"7322","DOI":"10.1038\/s41467-023-42948-2","article-title":"Lung SORT LNPs enable precise homology-directed repair mediated CRISPR\/Cas genome correction in cystic fibrosis models","volume":"14","author":"Wei","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.jcf.2026.04.007_bib0015","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ymthe.2021.03.023","article-title":"Targeted replacement of full-length CFTR in human airway stem cells by CRISPR-Cas9 for pan-mutation correction in the endogenous locus","volume":"30","author":"Vaidyanathan","year":"2022","journal-title":"Mol Ther"},{"key":"10.1016\/j.jcf.2026.04.007_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102339","article-title":"DNA-PKcs inhibition improves sequential gene insertion of the full-length CFTR cDNA in airway stem cells","volume":"35","author":"Stack","year":"2024","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.jcf.2026.04.007_bib0017","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/s41587-020-0561-9","article-title":"Genome editing with CRISPR\u2013Cas nucleases, base editors, transposases and prime editors","volume":"38","author":"Anzalone","year":"2020","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jcf.2026.04.007_bib0018","doi-asserted-by":"crossref","first-page":"10558","DOI":"10.1093\/nar\/gkab788","article-title":"Functional correction of CFTR mutations in human airway epithelial cells using adenine base editors","volume":"49","author":"Krishnamurthy","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jcf.2026.04.007_bib0019","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.stem.2020.01.019","article-title":"CRISPR-based adenine editors correct nonsense mutations in a cystic fibrosis organoid biobank","volume":"26","author":"Geurts","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jcf.2026.04.007_bib0020","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1038\/s41467-020-15892-8","article-title":"Chemical modifications of adenine base editor mRNA and guide RNA expand its application scope","volume":"11","author":"Jiang","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.jcf.2026.04.007_bib0021","doi-asserted-by":"crossref","first-page":"8051","DOI":"10.1038\/s41467-023-43904-w","article-title":"Shuttle peptide delivers base editor RNPs to rhesus monkey airway epithelial cells in vivo","volume":"14","author":"Kulhankova","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.jcf.2026.04.007_bib0022","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.ymthe.2025.01.011","article-title":"Functional rescue of F508del-CFTR through revertant mutations introduced by CRISPR base editing","volume":"33","author":"Carrozzo","year":"2025","journal-title":"Mol Ther"},{"key":"10.1016\/j.jcf.2026.04.007_bib0023","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/j.ymthe.2023.03.004","article-title":"Functional restoration of a CFTR splicing mutation through RNA delivery of CRISPR adenine base editor","volume":"31","author":"Amistadi","year":"2023","journal-title":"Mol Ther"},{"key":"10.1016\/j.jcf.2026.04.007_bib0024","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.omtn.2023.06.020","article-title":"Protospacer modification improves base editing of a canonical splice site variant and recovery of CFTR function in human airway epithelial cells","volume":"33","author":"Joynt","year":"2023","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.jcf.2026.04.007_bib0025","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202000940","article-title":"Evaluating CRISPR-based prime editing for cancer modeling and CFTR repair in organoids","volume":"4","author":"Geurts","year":"2021","journal-title":"Life Sci Alliance"},{"key":"10.1016\/j.jcf.2026.04.007_bib0026","article-title":"Prime editing-mediated correction of the CFTR W1282X mutation in iPSCs and derived airway epithelial cells","volume":"18","author":"Li","year":"2023","journal-title":"PLOS ONE"},{"key":"10.1016\/j.jcf.2026.04.007_bib0027","article-title":"Prime editing functionally corrects cystic fibrosis-causing CFTR mutations in human organoids and airway epithelial cells","volume":"5","author":"Bulcaen","year":"2024","journal-title":"CR Med"},{"key":"10.1016\/j.jcf.2026.04.007_bib0028","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41551-024-01233-3","article-title":"Systematic optimization of prime editing for the efficient functional correction of CFTR F508del in human airway epithelial cells","volume":"9","author":"Sousa","year":"2025","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.jcf.2026.04.007_bib0029","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/s41586-025-09732-2","article-title":"Prime editing-installed suppressor tRNAs for disease-agnostic genome editing","volume":"648","author":"Pierce","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.jcf.2026.04.007_bib0030","doi-asserted-by":"crossref","first-page":"5199","DOI":"10.1126\/science.adt5199","article-title":"Programmable gene insertion in human cells with a laboratory-evolved CRISPR-associated transposase","volume":"388","author":"Witte","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.jcf.2026.04.007_bib0031","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/s41587-022-01527-4","article-title":"Drag-and-drop genome insertion of large sequences without double-strand DNA cleavage using CRISPR-directed integrases","volume":"41","author":"Yarnall","year":"2023","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jcf.2026.04.007_bib0032","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41551-024-01227-1","article-title":"Efficient site-specific integration of large genes in mammalian cells via continuously evolved recombinases and prime editing","volume":"9","author":"Pandey","year":"2025","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.jcf.2026.04.007_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102636","article-title":"Off-target effects in CRISPR-Cas genome editing for human therapeutics: progress and challenges","volume":"36","author":"Kalter","year":"2025","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.jcf.2026.04.007_bib0034","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/s41588-021-00838-7","article-title":"Chromothripsis as an on-target consequence of CRISPR\u2013Cas9 genome editing","volume":"53","author":"Leibowitz","year":"2021","journal-title":"Nat Genet"},{"key":"10.1016\/j.jcf.2026.04.007_bib0035","first-page":"1","article-title":"Genotoxic effects of base and prime editing in human hematopoietic stem cells","author":"Fiumara","year":"2023","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jcf.2026.04.007_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2023.102066","article-title":"Progress and harmonization of gene editing to treat human diseases: proceeding of COST Action CA21113 GenE-HumDi","volume":"34","author":"Cavazza","year":"2023","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.jcf.2026.04.007_bib0037","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1038\/s41586-025-09537-3","article-title":"Engineered prime editors with minimal genomic errors","volume":"646","author":"Chauhan","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.jcf.2026.04.007_bib0038","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2307798120","article-title":"Recent advances in nanoparticulate RNA delivery systems","volume":"121","author":"Witten","year":"2024","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.jcf.2026.04.007_bib0039","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa2107454","article-title":"CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis","volume":"385","author":"Gillmore","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcf.2026.04.007_bib0040","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.jcf.2023.04.008","article-title":"Inhaled mRNA therapy for treatment of cystic fibrosis: interim results of a randomized, double-blind, placebo-controlled phase 1\/2 clinical study","volume":"22","author":"Rowe","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.04.007_bib0041","first-page":"1","article-title":"Artificial intelligence-guided design of lipid nanoparticles for pulmonary gene therapy","author":"Witten","year":"2024","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jcf.2026.04.007_bib0042","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2418731122","article-title":"Systemic in utero gene editing as a treatment for cystic fibrosis","volume":"122","author":"Ricciardi","year":"2025","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.jcf.2026.04.007_bib0043","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.omtm.2022.07.002","article-title":"Sendai F\/HN pseudotyped lentiviral vector transduces human ciliated and non-ciliated airway cells using \u03b1 2,3 sialylated receptors","volume":"26","author":"Munday","year":"2022","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.jcf.2026.04.007_bib0044","first-page":"1","article-title":"Combinatorial development of nebulized mRNA delivery formulations for the lungs","author":"Jiang","year":"2023","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.jcf.2026.04.007_bib0045","doi-asserted-by":"crossref","first-page":"11335","DOI":"10.1021\/acsnano.4c00768","article-title":"Microfluidic platform enables shearless aerosolization of lipid nanoparticles for mRNA inhalation","volume":"18","author":"Kim","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jcf.2026.04.007_bib0046","article-title":"Inhalable dry powders for lung mRNA delivery","volume":"13","author":"Gordon","year":"2024","journal-title":"Adv Heal Mater"},{"key":"10.1016\/j.jcf.2026.04.007_bib0047","doi-asserted-by":"crossref","first-page":"6477","DOI":"10.1038\/s41467-025-61688-z","article-title":"Boosting RNA nanotherapeutics with V-ATPase activating non-inflammatory lipid nanoparticles to treat chronic lung injury","volume":"16","author":"Zhao","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.jcf.2026.04.007_bib0048","article-title":"LUMI-lab: a foundation model-driven autonomous platform enabling discovery of new ionizable lipid designs for mRNA delivery","author":"Cui","year":"2025","journal-title":"20250214638383 Prepr at"},{"key":"10.1016\/j.jcf.2026.04.007_bib0049","first-page":"1","article-title":"Limiting endosomal damage sensing reduces inflammation triggered by lipid nanoparticle endosomal escape","author":"Omo-Lamai","year":"2025","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.jcf.2026.04.007_bib0050","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202312026","article-title":"Physicochemical targeting of lipid nanoparticles to the lungs induces clotting: mechanisms and solutions","volume":"36","author":"Omo-Lamai","year":"2024","journal-title":"Adv Mater"},{"key":"10.1016\/j.jcf.2026.04.007_bib0051","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1126\/science.adk9428","article-title":"In vivo editing of lung stem cells for durable gene correction in mice","volume":"384","author":"Sun","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.jcf.2026.04.007_bib0052","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1021\/acs.nanolett.3c00304","article-title":"In vivo RNA delivery to hematopoietic stem and progenitor cells via targeted lipid nanoparticles","volume":"23","author":"Shi","year":"2023","journal-title":"Nano Lett"},{"key":"10.1016\/j.jcf.2026.04.007_bib0053","first-page":"1","article-title":"Tissue-specific mRNA delivery and prime editing with peptide\u2013ionizable lipid nanoparticles","author":"Lin","year":"2025","journal-title":"Nat Mater"},{"issue":"40","key":"10.1016\/j.jcf.2026.04.007_bib0054","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202507657","article-title":"Reengineering endogenous targeting lipid nanoparticles (ENDO) for systemic delivery of mRNA to pancreas","volume":"37","author":"Isaac","year":"2025","journal-title":"Adv Mater"},{"key":"10.1016\/j.jcf.2026.04.007_bib0055","doi-asserted-by":"crossref","first-page":"eadw0730","DOI":"10.1126\/sciadv.adw0730","article-title":"Lipid nanoparticles for mRNA delivery in brain via systemic administration","volume":"11","author":"Cao","year":"2025","journal-title":"Sci Adv"},{"key":"10.1016\/j.jcf.2026.04.007_bib0056","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2307801120","article-title":"Cationic cholesterol-dependent LNP delivery to lung stem cells, the liver, and heart","volume":"121","author":"Radmand","year":"2024","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.jcf.2026.04.007_bib0057","first-page":"387","article-title":"In utero delivery of mRNA to the heart, diaphragm and muscle with lipid nanoparticles","volume":"25","author":"Gao","year":"2023","journal-title":"Bioact Mater"},{"key":"10.1016\/j.jcf.2026.04.007_bib0058","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1039\/C8BM00637G","article-title":"Intracellular delivery and biodistribution study of CRISPR\/Cas9 ribonucleoprotein loaded bioreducible lipidoid nanoparticles","volume":"7","author":"Li","year":"2019","journal-title":"Biomater Sci"},{"key":"10.1016\/j.jcf.2026.04.007_bib0059","first-page":"1","article-title":"Safer non-viral DNA delivery using lipid nanoparticles loaded with endogenous anti-inflammatory lipids","author":"Patel","year":"2025","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jcf.2026.04.007_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102502","article-title":"Inhibition of IFNAR-JAK signaling enhances tolerability and transgene expression of systemic non-viral DNA delivery","volume":"36","author":"Senapati","year":"2025","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.jcf.2026.04.007_bib0061","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-66318-2","article-title":"Circular single stranded DNA potentiates non-viral gene insertion in hematopoietic stem and progenitor cells","volume":"16","author":"Letort","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.jcf.2026.04.007_bib0062","first-page":"1","article-title":"Immune evasive DNA donors and recombinases license kilobase-scale writing","author":"Tou","year":"2026","journal-title":"Nature"},{"key":"10.1016\/j.jcf.2026.04.007_bib0063","article-title":"Multi-stage-mixing to create a core-then-shell structure improves DNA-loaded lipid nanoparticles\u2019 transfection by orders of magnitude","author":"Nong","year":"2024","journal-title":"20241112623321 Prepr at"},{"key":"10.1016\/j.jcf.2026.04.007_bib0064","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.addr.2020.06.014","article-title":"Polymeric vehicles for nucleic acid delivery","volume":"156","author":"Piotrowski-Daspit","year":"2020","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.jcf.2026.04.007_bib0065","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jconrel.2018.07.001","article-title":"PEGylated enhanced cell penetrating peptide nanoparticles for lung gene therapy","volume":"285","author":"Osman","year":"2018","journal-title":"J Control Release"},{"key":"10.1016\/j.jcf.2026.04.007_bib0066","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1136\/thoraxjnl-2020-215185","article-title":"Inhaled gene therapy of preclinical muco-obstructive lung diseases by nanoparticles capable of breaching the airway mucus barrier","volume":"77","author":"Kim","year":"2022","journal-title":"Thorax"},{"key":"10.1016\/j.jcf.2026.04.007_bib0067","doi-asserted-by":"crossref","first-page":"6952","DOI":"10.1038\/ncomms7952","article-title":"Nanoparticles that deliver triplex-forming peptide nucleic acid molecules correct F508del CFTR in airway epithelium","volume":"6","author":"McNeer","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.jcf.2026.04.007_bib0068","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/adhm.201400355","article-title":"Modified poly(lactic-co-glycolic acid) nanoparticles for enhanced cellular uptake and gene editing in the lung","volume":"4","author":"Fields","year":"2015","journal-title":"Adv Heal Mater"},{"key":"10.1016\/j.jcf.2026.04.007_bib0069","doi-asserted-by":"crossref","first-page":"eabo0522","DOI":"10.1126\/sciadv.abo0522","article-title":"In vivo correction of cystic fibrosis mediated by PNA nanoparticles","volume":"8","author":"Piotrowski-Daspit","year":"2022","journal-title":"Sci Adv"},{"key":"10.1016\/j.jcf.2026.04.007_bib0070","doi-asserted-by":"crossref","first-page":"eabq0603","DOI":"10.1126\/scitranslmed.abq0603","article-title":"Polymer nanoparticles deliver mRNA to the lung for mucosal vaccination","volume":"15","author":"Suberi","year":"2023","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jcf.2026.04.007_bib0071","doi-asserted-by":"crossref","first-page":"6769","DOI":"10.1038\/s41467-021-26830-7","article-title":"Cas9-specific immune responses compromise local and systemic AAV CRISPR therapy in multiple dystrophic canine models","volume":"12","author":"Hakim","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.jcf.2026.04.007_bib0072","doi-asserted-by":"crossref","DOI":"10.1093\/immhor\/vlaf041","article-title":"Detection of pre-existing immunity to bacterial Cas9 proteins in people with cystic fibrosis","volume":"9","author":"Serpa","year":"2025","journal-title":"Immunohorizons"},{"key":"10.1016\/j.jcf.2026.04.007_bib0073","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41591-018-0326-x","article-title":"Identification of preexisting adaptive immunity to Cas9 proteins in humans","volume":"25","author":"Charlesworth","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.jcf.2026.04.007_bib0074","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ymthe.2021.07.011","article-title":"Dual-AAV delivering split prime editor system for in vivo genome editing","volume":"30","author":"Zhi","year":"2022","journal-title":"Mol Ther"},{"key":"10.1016\/j.jcf.2026.04.007_bib0075","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/s41551-022-00911-4","article-title":"Efficient in vivo base editing via single adeno-associated viruses with size-optimized genomes encoding compact adenine base editors","volume":"6","author":"Davis","year":"2022","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.jcf.2026.04.007_bib0076","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13059-024-03215-9","article-title":"Eukaryotic-driven directed evolution of Cas9 nucleases","volume":"25","author":"Ruta","year":"2024","journal-title":"Genome Biol"},{"key":"10.1016\/j.jcf.2026.04.007_bib0077","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1038\/s41587-023-02078-y","article-title":"Engineered virus-like particles for transient delivery of prime editor ribonucleoprotein complexes in vivo","volume":"42","author":"An","year":"2024","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jcf.2026.04.007_bib0078","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.cell.2021.12.021","article-title":"Engineered virus-like particles for efficient in vivo delivery of therapeutic proteins","volume":"185","author":"Banskota","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.jcf.2026.04.007_bib0079","first-page":"1","article-title":"Directed evolution of engineered virus-like particles with improved production and transduction efficiencies","author":"Raguram","year":"2024","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jcf.2026.04.007_bib0080","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1089\/hum.2024.258","article-title":"Trojan horse-like vehicles for CRISPR-Cas delivery: engineering extracellular vesicles and virus-like particles for precision gene editing in cystic fibrosis","volume":"36","author":"Dipalo","year":"2025","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.jcf.2026.04.007_bib0081","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S2213-2600(15)00245-3","article-title":"Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial","volume":"3","author":"Alton","year":"2015","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jcf.2026.04.007_bib0082","series-title":"Electroporation-mediated gene delivery of CFTR plasmids as a novel approach to treat cystic fibrosis in vivo","author":"Delemos","year":"2025"},{"key":"10.1016\/j.jcf.2026.04.007_bib0083","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1126\/science.abg6155","article-title":"Mammalian retrovirus-like protein PEG10 packages its own mRNA and can be pseudotyped for mRNA delivery","volume":"373","author":"Segel","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.jcf.2026.04.007_bib0084","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.jcyt.2025.06.010","article-title":"Advancing gene-editing platforms to improve the viability of rare-disease therapeutics: key insights from a 2024 scientific exchange hosted by ARM, ISCT, and danaher","volume":"27","author":"Urnov","year":"2025","journal-title":"Cytotherapy"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199326001001?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199326001001?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T06:27:54Z","timestamp":1783146474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199326001001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":84,"alternative-id":["S1569199326001001"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2026.04.007","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progress and challenges in cystic fibrosis gene editing","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2026.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.","name":"copyright","label":"Copyright"}]}}